Venture Capital

Updated:

Data Science Ventures

Srinivas Akkaraju co-founded Data Science Ventures in 2016, deploying quantitative screening to find technical founders at Seed and Series A.

Data Science Ventures

Data Science Ventures was founded in 2016 by Srinivas Akkaraju, a former Genentech executive and healthcare investor, alongside Naveen Bhatia. The firm emerged from a thesis that machine learning could systematically identify high-potential technical founders earlier than conventional networks. Rather than relying on warm introductions and geographic concentration, DSV built a data ingestion engine that analyzes patent filings, academic publications, technical hiring patterns, and product launch trajectories — a scouting infrastructure unusual for a firm of its vintage and size. The firm invests primarily at the Seed and Series A stages, with check sizes typically ranging from $1 million to $5 million. Its strategy spans enterprise software, AI/ML infrastructure, digital health, fintech, and cybersecurity. DSV reserves significant capital for follow-on investments in portfolio companies that demonstrate technical milestones and product-market traction. Public portfolio exposure includes positions in AI-native drug discovery platforms, machine learning operations tooling, and precision medicine diagnostics. Geographic coverage leans heavily on US-based startups, with selective co-investments in Canadian and UK technical hubs where deep talent pools intersect with strong IP regimes. DSV maintains a lean partnership structure with Akkaraju overseeing life sciences and digital health allocation while Bhatia leads enterprise and infrastructure investing. The firm has not publicly disclosed total AUM or headcount, consistent with its posture as a tightly held early-stage specialist. In March 2024, DSV participated in a Series A round for a computational biology startup applying transformer models to protein design (per Crunchbase, 2024). The firm occasionally syndicates with more generalist, multi-stage funds when portfolio companies require larger growth rounds, but its origination remains independent. What structurally differentiates DSV is its sourcing model — an algorithmic discovery layer that operates continuously, screening for technical founders before they actively fundraise. This quantitative top-of-funnel approach sidesteps the relationship-dependency that characterizes most Seed-stage venture firms. The architecture lets a small partnership maintain a high-volume, technically filtered deal pipeline without scaling headcount proportionally.

Website
dsvcap.com

General information

Firm type

Venture Capital

Year founded

2016

AUM

Undisclosed

Location

Region

North America

Country

United States

City

New York

Corporate office

New York, NY, United States

Principals

Srinivas Akkaraju

Founder & Managing Partner

Naveen Bhatia

Managing Partner

Sector focus

AI/MLEnterprise SoftwareDigital HealthFinTechCybersecurity

Frequently asked questions

Who runs investment decisions at Data Science Ventures?

Srinivas Akkaraju and Naveen Bhatia serve as Managing Partners. Akkaraju leads life sciences and digital health investments, drawing on his background as a former Genentech executive. Bhatia oversees enterprise software, AI infrastructure, and fintech allocations. Investment committee decisions require consensus between both partners, keeping the process concentrated and internal.

How does DSV source proprietary deal flow?

DSV deploys a proprietary machine learning engine that scans patent databases, academic citation networks, technical job postings, and product launch records. The system surfaces early-stage technical founders before they engage traditional venture networks. This algorithmic top-of-funnel replaces the warm-introduction model with quantifiable technical signals, aiming to reach founders six to twelve months ahead of formal fundraising processes.

What investment stages does Data Science Ventures target?

The firm concentrates on Seed and Series A rounds, with initial checks typically between $1 million and $5 million. DSV reserves follow-on capital for portfolio companies reaching defined technical milestones, though it does not lead later-stage rounds internally. When portfolio companies require large growth financing, DSV syndicates with multi-stage venture partners who joined the cap table earlier through co-investment or direct introduction.

Which sectors does Data Science Ventures explicitly avoid?

DSV avoids consumer internet, enterprise SaaS with no defensible technical moat, and capital-intensive hardware requiring factory-scale manufacturing. The firm also declines to invest in companies whose value proposition depends solely on branding or network effects without underlying computational or scientific IP. This exclusion reflects the modeling constraint — the data engine requires structured technical signals to generate actionable leads.

Does DSV maintain a fund-of-funds allocation, or does it invest only directly?

DSV invests exclusively through direct equity in portfolio companies. There is no fund-of-funds program, no LP commitments to external venture firms, and no secondary-market purchasing activity. The firm has not announced plans to launch a separate growth-stage vehicle or a dedicated opportunity fund, operating instead through a single core early-stage strategy.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More New York Venture Capital profiles